FDA panel unanimously recommends approval for dabigatran - Cardiology Today Print
Cardiology TodayThe FDA's Cardiovascular and Renal Drugs Advisory Committee has voted 9-0 for approval of the investigational anticoagulant dabigatran, according to a press ...FDA Committee Unanimously Supports Boehringer Ingelheim's Stroke-Prevention

... read more